Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ali Musani

Concepts (289)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bronchoscopy
45
2023
245
12.420
 Why?
Pulmonary Medicine
17
2023
88
7.700
 Why?
Lung Neoplasms
15
2020
2207
2.280
 Why?
Certification
4
2020
90
2.120
 Why?
Lung Diseases
7
2019
710
1.960
 Why?
Pleural Effusion, Malignant
6
2017
14
1.770
 Why?
Pulmonologists
3
2023
16
1.730
 Why?
Pneumonectomy
4
2020
126
1.660
 Why?
Photochemotherapy
4
2020
29
1.520
 Why?
Endosonography
6
2019
140
1.360
 Why?
Pleural Diseases
4
2019
21
1.350
 Why?
Societies, Medical
6
2020
684
1.200
 Why?
Pulmonary Emphysema
5
2020
316
1.170
 Why?
Airway Obstruction
7
2015
168
1.160
 Why?
Tracheal Stenosis
5
2015
24
1.100
 Why?
Tracheobronchomalacia
2
2018
14
1.030
 Why?
Stents
9
2016
475
1.030
 Why?
Bronchi
8
2018
250
1.020
 Why?
Tracheal Neoplasms
2
2015
11
0.910
 Why?
Precancerous Conditions
2
2015
156
0.900
 Why?
Bronchial Diseases
2
2013
38
0.870
 Why?
Physician's Role
2
2019
199
0.860
 Why?
Carcinoma, Non-Small-Cell Lung
3
2020
963
0.820
 Why?
Tracheostomy
4
2020
100
0.800
 Why?
Brachytherapy
2
2020
104
0.750
 Why?
Humans
73
2023
115613
0.720
 Why?
Rare Diseases
2
2019
89
0.720
 Why?
Biopsy
5
2019
1056
0.700
 Why?
Eligibility Determination
1
2020
60
0.690
 Why?
Foreign Bodies
2
2018
99
0.690
 Why?
Lung
8
2019
3673
0.670
 Why?
Pleurodesis
4
2013
7
0.670
 Why?
Thoracoscopy
6
2019
53
0.660
 Why?
Clinical Competence
5
2020
912
0.650
 Why?
Pulmonary Disease, Chronic Obstructive
4
2019
1098
0.650
 Why?
Cryosurgery
2
2019
52
0.630
 Why?
Photosensitizing Agents
2
2018
26
0.620
 Why?
Dihematoporphyrin Ether
1
2018
3
0.620
 Why?
Optical Imaging
2
2015
55
0.610
 Why?
Radiology, Interventional
1
2018
28
0.600
 Why?
Ablation Techniques
2
2019
29
0.600
 Why?
Cough
1
2018
107
0.570
 Why?
Thoracic Surgery, Video-Assisted
1
2017
40
0.570
 Why?
Bronchoscopes
2
2013
4
0.570
 Why?
Tracheal Diseases
2
2016
15
0.560
 Why?
Electromagnetic Phenomena
2
2012
22
0.510
 Why?
Prostheses and Implants
2
2014
140
0.510
 Why?
Precision Medicine
1
2019
344
0.510
 Why?
Bronchial Neoplasms
1
2015
14
0.500
 Why?
Bronchial Fistula
1
2015
4
0.500
 Why?
Respiratory Insufficiency
2
2020
292
0.480
 Why?
Hydrogel, Polyethylene Glycol Dimethacrylate
1
2015
74
0.470
 Why?
Emphysema
1
2014
124
0.430
 Why?
Light
2
2015
337
0.430
 Why?
Tracheomalacia
1
2012
19
0.420
 Why?
Signal Processing, Computer-Assisted
1
2013
137
0.420
 Why?
Endoscopy
1
2015
247
0.420
 Why?
Solitary Pulmonary Nodule
2
2012
25
0.410
 Why?
Carcinoid Tumor
1
2012
25
0.400
 Why?
Mass Screening
1
2019
1024
0.400
 Why?
Lung Diseases, Interstitial
1
2017
520
0.390
 Why?
Esophageal Neoplasms
1
2015
273
0.390
 Why?
Adenocarcinoma
1
2018
799
0.380
 Why?
Paraganglioma
1
2012
47
0.380
 Why?
Thoracentesis
2
2022
8
0.380
 Why?
Kidney Neoplasms
1
2015
326
0.370
 Why?
Drainage
4
2017
151
0.370
 Why?
Epithelial Cells
2
2015
961
0.370
 Why?
Infectious Disease Transmission, Patient-to-Professional
2
2020
21
0.360
 Why?
Catheters, Indwelling
4
2017
79
0.350
 Why?
Primary Health Care
1
2019
1518
0.330
 Why?
Colorectal Neoplasms
1
2015
617
0.310
 Why?
Forced Expiratory Volume
4
2020
516
0.310
 Why?
Ultrasonography, Interventional
2
2022
125
0.300
 Why?
Correspondence as Topic
1
2007
15
0.300
 Why?
Tomography, X-Ray Computed
8
2018
2392
0.300
 Why?
Bereavement
1
2007
49
0.290
 Why?
Betacoronavirus
2
2020
254
0.290
 Why?
Treatment Outcome
11
2020
9159
0.280
 Why?
Sensitivity and Specificity
3
2017
1718
0.270
 Why?
Professional-Family Relations
1
2007
138
0.270
 Why?
United States
7
2023
12297
0.260
 Why?
Mediastinal Neoplasms
1
2005
32
0.250
 Why?
Pneumonia, Viral
2
2020
344
0.250
 Why?
Coronavirus Infections
2
2020
336
0.250
 Why?
Educational Measurement
2
2020
262
0.250
 Why?
Equipment Design
4
2013
517
0.230
 Why?
Foreign-Body Migration
2
2015
38
0.230
 Why?
Catheterization, Peripheral
1
2004
102
0.220
 Why?
Diagnosis, Differential
4
2012
1357
0.220
 Why?
Catheterization
2
2019
159
0.220
 Why?
Neoplasm Staging
3
2020
1178
0.210
 Why?
Intubation, Intratracheal
2
2016
215
0.210
 Why?
Electrocoagulation
2
2013
38
0.200
 Why?
Immunohistochemistry
2
2019
1642
0.200
 Why?
Pneumonia
3
2019
576
0.190
 Why?
Male
19
2023
55968
0.190
 Why?
Biopsy, Needle
2
2012
183
0.190
 Why?
Climate Change
1
2023
124
0.190
 Why?
Education, Medical, Graduate
2
2017
376
0.190
 Why?
Asthma
6
2019
2066
0.190
 Why?
Network Meta-Analysis
1
2020
16
0.190
 Why?
Mediastinum
1
2020
21
0.180
 Why?
Ultrasonography
2
2022
642
0.180
 Why?
Inventions
1
2020
17
0.180
 Why?
Chronic Disease
2
2018
1598
0.170
 Why?
Pathologists
1
2019
15
0.170
 Why?
Education
1
2020
99
0.170
 Why?
Bronchial Thermoplasty
1
2019
1
0.170
 Why?
Oncologists
1
2019
31
0.170
 Why?
Specimen Handling
1
2020
156
0.170
 Why?
Infection Control
1
2020
136
0.160
 Why?
Bronchoalveolar Lavage Fluid
4
2008
608
0.160
 Why?
Female
17
2023
59932
0.160
 Why?
Chest Tubes
2
2009
31
0.160
 Why?
Image-Guided Biopsy
1
2018
33
0.160
 Why?
Neoplasms
2
2008
2118
0.150
 Why?
Community-Acquired Infections
1
2019
141
0.150
 Why?
Logistic Models
2
2012
1856
0.140
 Why?
Dogs
1
2018
341
0.140
 Why?
Prognosis
2
2019
3339
0.140
 Why?
Lung Volume Measurements
2
2014
45
0.140
 Why?
Accreditation
1
2017
78
0.140
 Why?
High-Throughput Nucleotide Sequencing
1
2019
443
0.140
 Why?
Fellowships and Scholarships
2
2017
241
0.140
 Why?
Middle Aged
11
2017
27014
0.130
 Why?
Iatrogenic Disease
1
2016
51
0.130
 Why?
Tumor Burden
1
2017
261
0.130
 Why?
Radiography
2
2012
826
0.130
 Why?
Absorbable Implants
1
2015
34
0.130
 Why?
Pandemics
2
2020
1334
0.130
 Why?
Narrow Band Imaging
1
2015
15
0.130
 Why?
Aged
7
2016
19255
0.130
 Why?
Safety
1
2017
298
0.130
 Why?
Intraoperative Complications
1
2016
126
0.130
 Why?
Physicians
1
2023
776
0.120
 Why?
Recurrence
4
2017
952
0.120
 Why?
Collagen Type III
3
2004
18
0.120
 Why?
Trachea
1
2016
233
0.120
 Why?
Bronchial Provocation Tests
3
2004
53
0.120
 Why?
Postoperative Complications
2
2019
2161
0.120
 Why?
Adult
12
2015
30726
0.110
 Why?
Lung Transplantation
2
2014
246
0.110
 Why?
Fiber Optic Technology
1
2013
17
0.110
 Why?
Device Removal
2
2012
128
0.110
 Why?
Paracentesis
1
2013
7
0.110
 Why?
Cryotherapy
1
2013
16
0.110
 Why?
Retrospective Studies
6
2016
12608
0.110
 Why?
Contraindications
1
2013
86
0.110
 Why?
Metals
1
2014
109
0.110
 Why?
Prosthesis Implantation
1
2014
139
0.110
 Why?
Glaucoma Drainage Implants
1
2013
47
0.110
 Why?
Exercise Tolerance
1
2014
223
0.100
 Why?
Gastroscopy
1
2012
18
0.100
 Why?
Silicones
1
2012
21
0.100
 Why?
Laser Therapy
1
2013
99
0.100
 Why?
Brain Abscess
1
2012
11
0.100
 Why?
Pulmonary Alveolar Proteinosis
1
2012
16
0.100
 Why?
Hemoptysis
1
2012
35
0.100
 Why?
Genetic Therapy
1
2013
260
0.100
 Why?
Time Factors
4
2017
6165
0.100
 Why?
Lasers, Solid-State
1
2011
22
0.100
 Why?
Respiratory Sounds
1
2012
111
0.100
 Why?
Debridement
1
2011
75
0.100
 Why?
Laryngoscopy
1
2012
92
0.090
 Why?
Pulmonary Surgical Procedures
1
2011
8
0.090
 Why?
Respiratory Tract Fistula
1
2011
8
0.090
 Why?
Hypnotics and Sedatives
1
2012
134
0.090
 Why?
Curriculum
1
2017
853
0.090
 Why?
Exercise Therapy
1
2014
351
0.090
 Why?
Recovery of Function
1
2014
577
0.090
 Why?
Walking
1
2014
425
0.090
 Why?
Surveys and Questionnaires
3
2020
4668
0.090
 Why?
Bronchial Hyperreactivity
1
2010
96
0.080
 Why?
Fibroblasts
3
2004
839
0.080
 Why?
Sclerotherapy
1
2009
19
0.080
 Why?
Follow-Up Studies
3
2017
4440
0.080
 Why?
Pneumothorax
1
2009
42
0.080
 Why?
Image Processing, Computer-Assisted
1
2013
691
0.080
 Why?
Feasibility Studies
1
2012
741
0.080
 Why?
Allergens
2
2004
418
0.080
 Why?
Seizures
1
2012
344
0.080
 Why?
Disease Models, Animal
1
2018
3580
0.080
 Why?
Pleural Cavity
1
2008
2
0.080
 Why?
Pulmonary Alveoli
1
2011
376
0.080
 Why?
Pulmonary Surfactant-Associated Protein D
1
2008
31
0.080
 Why?
Hypertension, Pulmonary
1
2019
1749
0.080
 Why?
Faculty, Medical
2
2023
234
0.070
 Why?
Forms and Records Control
1
2007
22
0.070
 Why?
Aged, 80 and over
2
2012
6419
0.070
 Why?
Steroids
1
2008
147
0.070
 Why?
Incidence
1
2013
2335
0.070
 Why?
Reimbursement Mechanisms
1
2007
78
0.070
 Why?
Granulation Tissue
1
2006
6
0.070
 Why?
Child
2
2018
18487
0.070
 Why?
Patient Selection
2
2020
654
0.070
 Why?
Empathy
1
2007
140
0.070
 Why?
Cytosine
1
2006
44
0.070
 Why?
Thymus Neoplasms
1
2005
21
0.060
 Why?
Thymoma
1
2005
31
0.060
 Why?
Muscle, Smooth
2
2004
150
0.060
 Why?
Pediatrics
1
2013
986
0.060
 Why?
Organophosphonates
1
2006
91
0.060
 Why?
Prospective Studies
2
2013
6264
0.060
 Why?
Teratoma
1
2005
92
0.060
 Why?
Lymphoma
1
2005
178
0.060
 Why?
Smoking
1
2012
1457
0.060
 Why?
Actins
2
2004
383
0.060
 Why?
Decision Support Techniques
1
2007
353
0.060
 Why?
Interleukin-13
1
2004
126
0.060
 Why?
Transforming Growth Factors
1
2003
3
0.050
 Why?
Interleukin-4
1
2004
209
0.050
 Why?
Risk Assessment
1
2012
2987
0.050
 Why?
Zimbabwe
1
2022
42
0.050
 Why?
Salaries and Fringe Benefits
1
2023
53
0.050
 Why?
Thyroid Neoplasms
1
2005
262
0.050
 Why?
Prosthesis Design
2
2014
287
0.050
 Why?
Algorithms
1
2009
1491
0.050
 Why?
Benchmarking
1
2023
163
0.050
 Why?
Myofibrils
1
2002
46
0.050
 Why?
Transforming Growth Factor beta
1
2004
446
0.050
 Why?
Ambulatory Care
1
2004
479
0.050
 Why?
Pollen
1
2000
24
0.050
 Why?
Animals
3
2018
32102
0.050
 Why?
Plant Proteins
1
2000
81
0.040
 Why?
Infant
1
2013
7976
0.040
 Why?
Clinical Protocols
1
2020
233
0.040
 Why?
Interleukin-10
1
2000
299
0.040
 Why?
Consensus
1
2020
532
0.040
 Why?
Quality of Life
3
2017
2387
0.040
 Why?
Qualitative Research
1
2022
975
0.040
 Why?
France
1
2016
34
0.030
 Why?
Single-Blind Method
1
2017
255
0.030
 Why?
Tracheoesophageal Fistula
1
2016
31
0.030
 Why?
Airway Management
1
2016
60
0.030
 Why?
Cytokines
1
2003
1853
0.030
 Why?
Oxygen
2
2009
837
0.030
 Why?
Severity of Illness Index
2
2014
2578
0.030
 Why?
Dilatation
1
2014
59
0.030
 Why?
Risk Factors
2
2019
8699
0.030
 Why?
Breast Neoplasms
1
2004
1872
0.030
 Why?
Patient Satisfaction
1
2017
585
0.030
 Why?
Constriction, Pathologic
1
2014
210
0.030
 Why?
Prosthesis Failure
1
2014
116
0.030
 Why?
Specialization
1
2013
117
0.030
 Why?
Glucocorticoids
2
2010
552
0.020
 Why?
Anti-Inflammatory Agents
2
2008
448
0.020
 Why?
Compassionate Use Trials
1
2011
8
0.020
 Why?
Blood Gas Analysis
1
2009
69
0.020
 Why?
Anti-Bacterial Agents
1
2019
1485
0.020
 Why?
Critical Care
1
2013
477
0.020
 Why?
Radiometry
1
2008
43
0.020
 Why?
Pulmonary Circulation
1
2009
407
0.020
 Why?
Immune System
1
2008
173
0.020
 Why?
Exercise Test
1
2009
539
0.020
 Why?
Iridium Radioisotopes
1
2006
6
0.020
 Why?
Medical Oncology
1
2008
230
0.020
 Why?
Respiratory Tract Neoplasms
1
2006
2
0.020
 Why?
Radiotherapy Dosage
1
2006
246
0.020
 Why?
Administration, Inhalation
1
2008
644
0.020
 Why?
Papilloma
1
2006
43
0.020
 Why?
Thoracic Neoplasms
1
2006
33
0.020
 Why?
Injections
1
2006
161
0.020
 Why?
Pilot Projects
1
2009
1377
0.020
 Why?
Cells, Cultured
2
2004
3914
0.020
 Why?
Randomized Controlled Trials as Topic
1
2010
1218
0.020
 Why?
Models, Statistical
1
2008
606
0.010
 Why?
Secondary Prevention
1
2006
223
0.010
 Why?
Clinical Trials as Topic
1
2008
941
0.010
 Why?
Bronchoalveolar Lavage
1
2002
89
0.010
 Why?
Analysis of Variance
1
2004
1227
0.010
 Why?
Cohort Studies
1
2011
4945
0.010
 Why?
Magnetic Resonance Imaging
1
2012
3071
0.010
 Why?
Antigens, Plant
1
2000
47
0.010
 Why?
Poaceae
1
2000
64
0.010
 Why?
Dose-Response Relationship, Drug
1
2004
1870
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
795
0.010
 Why?
Rats
1
2008
5034
0.010
 Why?
Cell Culture Techniques
1
2002
344
0.010
 Why?
Apoptosis
1
2008
2377
0.010
 Why?
Blotting, Western
1
2002
1153
0.010
 Why?
Dexamethasone
1
2000
316
0.010
 Why?
Eosinophils
1
2000
282
0.010
 Why?
Cross-Sectional Studies
1
2008
4438
0.010
 Why?
Kinetics
1
2000
1569
0.010
 Why?
Case-Control Studies
1
2004
3023
0.010
 Why?
Young Adult
1
2011
10487
0.010
 Why?
Macrophages
1
2000
1284
0.010
 Why?
Adolescent
1
2011
17903
0.010
 Why?
Musani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (289) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)